Shanghai General Hospital Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02568020
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai Central Hospital | Xun Xu | YUAN Wei-jie

Active Ingredients

Drugs in Phase 4 Trials (1)

keto-amino acids (1 trial)

Drugs in Phase 1 Trials (1)

hy01 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 4)

Muscular Atrophy (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2